Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study

BACKGROUND: The purpose of this study was to evaluate the safety and efficacy of nimotuzumab in combination with chemotherapy (docetaxel and carboplatin) versus chemotherapy alone in patients with stage IIIB/IV non-small-cell lung cancer. METHODS: This multicenter, open-label, Phase II study randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Babu, K Govind, Prabhash, Kumar, Vaid, Ashok K, Sirohi, Bhawna, Diwakar, Ravi B, Rao, Raghunadha, Kar, Madhuchanda, Malhotra, Hemant, Nag, Shona, Goswami, Chanchal, Raina, Vinod, Mohan, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063861/
https://www.ncbi.nlm.nih.gov/pubmed/24966687
http://dx.doi.org/10.2147/OTT.S63168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063861/
https://www.ncbi.nlm.nih.gov/pubmed/24966687
http://dx.doi.org/10.2147/OTT.S63168

Ejemplares similares